差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 CytomX Therapeutics Inc - CTMX CFD

1.86
0%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.05
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 1.85
開盤價* 1.78
1 年變化* -3.78%
日範圍* 1.78 - 1.95
52 周範圍 1.17-3.12
平均交易量（10 天） 1.25M
平均交易量（3 個月） 52.84M
市值 118.95M
市盈率 -100.00K
流通股 66.08M
收入 71.94M
EPS -1.49
股息（收益率 %） N/A
貝塔 0.70
下一個財報發布日期 Mar 23, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Jun 29, 2022 1.86 0.04 2.20% 1.82 1.96 1.78
Jun 28, 2022 1.85 -0.09 -4.64% 1.94 1.94 1.80
Jun 27, 2022 1.92 0.04 2.13% 1.88 1.97 1.83
Jun 24, 2022 1.87 -0.05 -2.60% 1.92 1.97 1.83
Jun 23, 2022 1.84 0.14 8.24% 1.70 1.85 1.70
Jun 22, 2022 1.77 0.12 7.27% 1.65 1.81 1.62
Jun 21, 2022 1.68 0.06 3.70% 1.62 1.71 1.58
Jun 17, 2022 1.58 -0.03 -1.86% 1.61 1.70 1.57
Jun 16, 2022 1.63 -0.04 -2.40% 1.67 1.67 1.57
Jun 15, 2022 1.70 0.07 4.29% 1.63 1.73 1.61
Jun 14, 2022 1.65 -0.05 -2.94% 1.70 1.72 1.64
Jun 13, 2022 1.71 -0.03 -1.72% 1.74 1.76 1.68
Jun 10, 2022 1.83 -0.02 -1.08% 1.85 1.85 1.77
Jun 9, 2022 1.92 0.07 3.78% 1.85 1.93 1.81
Jun 8, 2022 1.88 0.02 1.08% 1.86 1.98 1.86
Jun 7, 2022 1.86 0.16 9.41% 1.70 1.91 1.67
Jun 6, 2022 1.71 -0.06 -3.39% 1.77 1.83 1.71
Jun 3, 2022 1.76 0.22 14.29% 1.54 1.78 1.54
Jun 2, 2022 1.58 0.06 3.95% 1.52 1.59 1.49
Jun 1, 2022 1.53 -0.05 -3.16% 1.58 1.67 1.50

CytomX Therapeutics Inc Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018 2017
總收入 69.573 100.362 57.489 59.502 71.623
收入 69.573 100.362 57.489 59.502 71.623
總營業費用 153.354 148.967 168.384 137.376 117.882
銷售/一般/行政費用，總計 39.16 36.031 36.765 33.51 25.605
研究與開發 114.194 112.936 131.619 103.866 92.277
營業收入 -83.781 -48.605 -110.895 -77.874 -46.259
利息收入（費用），非經營淨值 0.255 1.836 8.365 7.641 2.674
其他，淨值 -0.083 -0.027 -0.135 -0.068 -0.027
稅前淨收入 -83.609 -46.796 -102.665 -70.301 -43.612
稅後淨收入 -83.609 -32.885 -102.238 -84.604 -68.799
未計算非常項目前的淨收益 -83.609 -32.885 -102.238 -84.604 -68.799
淨收入 -83.609 -32.885 -102.238 -84.604 -43.099
Total Adjustments to Net Income 0
普通股股東可獲收益 (不含非經常性項目) -83.609 -32.885 -102.238 -84.604 -68.799
普通股股東可獲收益 (含非經常性項目) -83.609 -32.885 -102.238 -84.604 -43.099
攤薄淨收入 -83.609 -32.885 -102.238 -84.604 -43.099
攤薄後加權平均股 64.1469 46.1456 45.3359 41.6644 37.1668
扣除特別項目的每股攤薄盈利 -1.3034 -0.71264 -2.25512 -2.03061 -1.85109
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -1.3034 -0.71264 -2.25512 -2.03061 -1.85109
非常規項目總計 25.7
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 17.136 19.727 17.587 16.288 15.971
收入 17.136 19.727 17.587 16.288 15.971
總營業費用 41.102 46.035 40.228 35.493 31.598
銷售/一般/行政費用，總計 10.543 9.456 11.085 9.393 9.227
研究與開發 30.559 36.579 29.143 26.1 22.371
營業收入 -23.966 -26.308 -22.641 -19.205 -15.627
利息收入（費用），非經營淨值 0.068 0.073 0.07 0.044 0.068
其他，淨值 0.013 0.007 -0.013 -0.082 0.005
稅前淨收入 -23.885 -26.228 -22.584 -19.243 -15.554
稅後淨收入 -23.885 -26.228 -22.584 -19.243 -15.554
未計算非常項目前的淨收益 -23.885 -26.228 -22.584 -19.243 -15.554
淨收入 -23.885 -26.228 -22.584 -19.243 -15.554
普通股股東可獲收益 (不含非經常性項目) -23.885 -26.228 -22.584 -19.243 -15.554
普通股股東可獲收益 (含非經常性項目) -23.885 -26.228 -22.584 -19.243 -15.554
攤薄淨收入 -23.885 -26.228 -22.584 -19.243 -15.554
攤薄後加權平均股 65.3937 65.3086 65.2081 65.056 60.9681
扣除特別項目的每股攤薄盈利 -0.36525 -0.4016 -0.34634 -0.29579 -0.25512
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.36525 -0.4016 -0.34634 -0.29579 -0.25512
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 310.301 324.013 303.335 445.475 388.601
現金和短期投資 305.226 316.119 296.145 436.127 374.11
現金等價物 205.53 191.859 188.425 247.577 177.548
短期投資 99.696 124.26 107.72 188.55 196.562
應收賬款總額，淨額 0.79 0.798 0.013 0.097 10.139
Accounts Receivable - Trade, Net 0.79 0.798 0.013 0.097 10.139
Prepaid Expenses 4.285 7.096 7.177 9.251 4.352
Total Assets 339.411 358.663 341.282 457.108 397.644
Property/Plant/Equipment, Total - Net 25.322 29.445 32.754 6.934 4.218
Property/Plant/Equipment, Total - Gross 39.154 40.871 41.804 13.88 9.426
Accumulated Depreciation, Total -13.832 -11.426 -9.05 -6.946 -5.208
Goodwill, Net 0.949 0.949 0.949 0.949 0.949
Intangibles, Net 1.021 1.167 1.312 1.458 1.604
Other Long Term Assets, Total 1.818 3.089 2.932 2.292 2.272
Total Current Liabilities 106.316 100.924 85.59 97.908 61.147
Accounts Payable 2.818 2.996 4.158 5.132 4.205
Accrued Expenses 34.236 23.059 30.051 26.724 16.383
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 69.262 74.869 51.381 66.052 40.559
Total Liabilities 250.032 308.86 290.169 326.225 327.748
Total Long Term Debt 0 0 0 0 0
Deferred Income Tax
Other Liabilities, Total 143.716 207.936 204.579 228.317 266.601
Total Equity 89.379 49.803 51.113 130.883 69.896
Common Stock 0.001 0.001 0.001 0.001 0.001
Additional Paid-In Capital 623.344 499.964 468.285 445.956 289.454
Retained Earnings (Accumulated Deficit) -533.724 -450.115 -417.23 -314.981 -219.465
Other Equity, Total -0.242 -0.047 0.057 -0.093 -0.094
Total Liabilities & Shareholders’ Equity 339.411 358.663 341.282 457.108 397.644
Total Common Shares Outstanding 65.3928 48.2518 45.5231 45.0832 38.4786
Preferred Stock - Non Redeemable, Net 0 0 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 268.444 310.301 240.998 271.005 400.008
現金和短期投資 262.53 305.226 236.289 266.177 393.796
現金等價物 163.488 205.53 236.284 256.146 329.666
短期投資 99.042 99.696 0.005 10.031 64.13
應收賬款總額，淨額 1.016 0.79 0.887 0.931 0.756
Accounts Receivable - Trade, Net 1.016 0.79 0.887 0.931 0.756
Prepaid Expenses 4.898 4.285 3.822 3.897 5.456
Total Assets 296.825 339.411 371.233 402.44 434.158
Property/Plant/Equipment, Total - Net 24.629 25.322 26.441 27.66 28.908
Goodwill, Net 0.949 0.949 0.949 0.949 0.949
Intangibles, Net 0.984 1.021 1.057 1.094 1.13
Other Long Term Assets, Total 1.819 1.818 1.819 1.818 3.163
Total Current Liabilities 102.766 106.316 99.772 93.377 98.049
Accounts Payable 1.721 2.818 1.516 1.755 2.582
Accrued Expenses 31.032 34.236 25.167 19.253 18.831
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 70.013 69.262 73.089 72.369 76.636
Total Liabilities 228.631 250.032 259.559 271.487 288.136
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 125.865 143.716 159.787 178.11 190.087
Total Equity 68.194 89.379 111.674 130.953 146.022
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 0.001 0.001 0.001 0.001 0.001
Additional Paid-In Capital 626.721 623.344 619.117 615.849 611.733
Retained Earnings (Accumulated Deficit) -557.609 -533.724 -507.496 -484.912 -465.669
Other Equity, Total -0.919 -0.242 0.052 0.015 -0.043
Total Liabilities & Shareholders’ Equity 296.825 339.411 371.233 402.44 434.158
Total Common Shares Outstanding 65.3984 65.3928 65.2491 65.157 65.0029
Long Term Investments 99.969 99.914
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 -83.609 -32.885 -102.238 -84.604 -43.099
經營活動産生的現金 -119.031 5.259 -140.48 -75.521 170.373
經營活動産生的現金 2.56 2.427 2.459 1.884 1.645
Deferred Taxes -0.513
非現金物品 16.572 17.437 18.474 15.177 22.375
營運資金的變化 -54.7 18.134 -59.321 -7.978 189.965
投資活動産生的現金 22.489 -18.718 79.701 5.926 -121.266
資本支出 -1.609 -2.309 -3.497 -3.788 -1.559
其他投資現金流量項目，總計 24.098 -16.409 83.198 9.714 -119.707
融資活動産生的現金 110.213 16.893 1.627 139.624 23.796
融資現金流項目 0 0
股票的發行（報廢），淨額 110.213 16.893 1.627 139.624 23.796
債務的發行（退還），淨額 0
現金淨變化 13.671 3.434 -59.152 70.029 72.903
Amortization 0.146 0.146 0.146
Cash Taxes Paid 0 0 13.061
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -23.885 -83.609 -57.381 -34.797 -15.554
Cash From Operating Activities -41.313 -119.031 -87.839 -58.139 -29.94
Cash From Operating Activities 0.565 2.56 1.921 1.278 0.638
Amortization 0.037 0.146 0.11 0.073 0.036
Non-Cash Items 4.179 16.572 12.235 8.274 3.934
Changes in Working Capital -22.209 -54.7 -44.724 -32.967 -18.994
Cash From Investing Activities -0.736 22.489 22.734 13 59.012
Capital Expenditures -0.736 -1.609 -1.364 -1.096 -0.982
Other Investing Cash Flow Items, Total 0 24.098 24.098 14.096 59.994
Cash From Financing Activities 0.007 110.213 109.53 109.426 108.735
Issuance (Retirement) of Stock, Net 0.007 110.213 109.53 109.426 108.735
Net Change in Cash -42.042 13.671 44.425 64.287 137.807
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
BVF Partners L.P. Hedge Fund 9.9809 6595801 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.9392 4585721 47760 2022-12-31 LOW
Tang Capital Management, LLC Hedge Fund 5.3121 3510445 10445 2022-12-31 MED
Acadian Asset Management LLC Investment Advisor/Hedge Fund 4.0154 2653576 0 2022-12-31 MED
Rubric Capital Management LP Hedge Fund 3.6415 2406449 0 2022-12-31 MED
Millennium Management LLC Hedge Fund 2.6024 1719811 1187298 2022-12-31 HIGH
Medical Strategy GmbH Investment Advisor 2.5583 1690646 0 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 2.0289 1340774 -464826 2022-12-31 HIGH
Two Sigma Investments, LP Hedge Fund 1.9581 1293989 408628 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.9432 1284168 -468950 2022-12-31 LOW
Laurion Capital Management LP Hedge Fund 1.9231 1270900 0 2022-12-31 HIGH
Assenagon Asset Management S.A. Investment Advisor 1.3844 914900 -150492 2022-12-31 HIGH
Fidelity Management & Research Company LLC Investment Advisor 1.0582 699283 15074 2022-12-31 LOW
Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 1.045 690609 -438449 2022-12-31 MED
Platinum Asset Management Investment Advisor/Hedge Fund 0.9621 635798 -593747 2022-12-31 LOW
D. E. Shaw & Co., L.P. Hedge Fund 0.9357 618374 128744 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9126 603075 15624 2022-12-31 LOW
Newtyn Management, LLC Hedge Fund 0.8625 570000 -230000 2022-12-31 MED
Oasis Management Company Ltd. Investment Advisor/Hedge Fund 0.818 540541 0 2022-12-31 LOW
Gluck (Frederick W) Individual Investor 0.8021 530069 0 2022-04-18 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

650 Gateway Blvd.
Suite 125
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

收入報表

  • Annual
  • Quarterly

人們也觀看

US100

12,806.80 Price
+1.790% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 1.9

Gold

1,982.96 Price
+0.550% 1D Chg, %
多頭倉位隔夜費用 -0.0086%
空頭倉位隔夜費用 0.0004%
隔夜費時間 21:00 (UTC)
價差 0.30

Oil - Crude

71.07 Price
+2.160% 1D Chg, %
多頭倉位隔夜費用 -0.0170%
空頭倉位隔夜費用 -0.0050%
隔夜費時間 21:00 (UTC)
價差 0.03

XRP/USD

0.44 Price
+3.290% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00427

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易